198 related articles for article (PubMed ID: 20388787)
1. ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.
Geng H; Rademacher BL; Pittsenbarger J; Huang CY; Harvey CT; Lafortune MC; Myrthue A; Garzotto M; Nelson PS; Beer TM; Qian DZ
Cancer Res; 2010 Apr; 70(8):3239-48. PubMed ID: 20388787
[TBL] [Abstract][Full Text] [Related]
2. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
3. CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
Qian DZ; Rademacher BL; Pittsenbarger J; Huang CY; Myrthue A; Higano CS; Garzotto M; Nelson PS; Beer TM
Prostate; 2010 Mar; 70(4):433-42. PubMed ID: 19866475
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
[TBL] [Abstract][Full Text] [Related]
5. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
6. [Infiltrating mast cells promote neuroendocrine differentiation and increase docetaxel resistance of prostate cancer cells by up-regulating p21].
Ou YH; Jiang YD; Li Q; Zhuang YJ; Dang Q; Tan WL
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):723-730. PubMed ID: 29997096
[TBL] [Abstract][Full Text] [Related]
7. microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.
Gao Q; Zheng J
Biomed Pharmacother; 2018 Jan; 97():528-534. PubMed ID: 29091904
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells.
Canfield SE; Zhu K; Williams SA; McConkey DJ
Mol Cancer Ther; 2006 Aug; 5(8):2043-50. PubMed ID: 16928825
[TBL] [Abstract][Full Text] [Related]
9. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
[TBL] [Abstract][Full Text] [Related]
10. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
12. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy.
Gomez LA; de Las Pozas A; Reiner T; Burnstein K; Perez-Stable C
Mol Cancer Ther; 2007 May; 6(5):1534-43. PubMed ID: 17513602
[TBL] [Abstract][Full Text] [Related]
14. Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells.
Gupta S; Weston A; Bearrs J; Thode T; Neiss A; Soldi R; Sharma S
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):349-357. PubMed ID: 27349498
[TBL] [Abstract][Full Text] [Related]
15. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
Gan L; Wang J; Xu H; Yang X
Prostate; 2011 Aug; 71(11):1158-66. PubMed ID: 21656826
[TBL] [Abstract][Full Text] [Related]
16. Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.
Sharma P; Patel D; Chaudhary J
Cancer Med; 2012 Oct; 1(2):187-97. PubMed ID: 23342268
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
18. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
Mantena SK; Sharma SD; Katiyar SK
Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
[TBL] [Abstract][Full Text] [Related]
20. Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.
Sumida T; Murase R; Onishi-Ishikawa A; McAllister SD; Hamakawa H; Desprez PY
BMC Cancer; 2013 Mar; 13():141. PubMed ID: 23517130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]